| 1 |
34793770 | The mTOR inhibitor everolimus attenuates tacrolimus-induced renal interstitial fibrosis in rats. | 2022 Jan 1 |
2 |
| 2 |
32541562 | Thirty Years of Tacrolimus in Clinical Practice. | 2021 Mar 1 |
1 |
| 3 |
33431785 | Suppression of Allograft Fibrosis by Regulation of Mammalian Target of Rapamycin-Related Protein Expression in Kidney-Transplanted Recipients Treated with Everolimus and Reduced Tacrolimus. | 2021 Jan 12 |
1 |
| 4 |
33830489 | Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review. | 2021 Jun |
1 |
| 5 |
34046945 | Efficacy and safety of mammalian target of rapamycin inhibitors following intestinal and multivisceral transplantation. | 2021 Jul |
1 |
| 6 |
34847842 | Can We Use mTOR Inhibitors for COVID-19 Therapy? | 2021 Nov 30 |
1 |
| 7 |
31413313 | A monocentric study of steroid-refractory acute graft-versus-host disease treatment with tacrolimus and mTOR inhibitor. | 2020 Jan |
1 |
| 8 |
32006551 | Characterization of three FK506-binding proteins in the entomopathogenic fungus Beauveria bassiana. | 2020 Mar |
3 |
| 9 |
32732848 | Use of De Novo mTOR Inhibitors in Hypersensitized Kidney Transplant Recipients: Experience From Clinical Practice. | 2020 Aug |
1 |
| 10 |
32956634 | Tacrolimus, a rapamycin target protein inhibitor, exerts anti-cystic echinococcosis effects both in vitro and in vivo. | 2020 Dec |
2 |
| 11 |
33145270 | Differential expression of genes related to calcineurin and mTOR signaling and regulatory miRNAs in peripheral blood from kidney recipients under tacrolimus-based therapy. | 2020 Sep |
3 |
| 12 |
30532015 | Rapamycin-inspired macrocycles with new target specificity. | 2019 Mar |
1 |
| 13 |
31271885 | Effect of Sirolimus on Immune Reconstitution Following Myeloablative Allogeneic Stem Cell Transplantation: An Ancillary Analysis of a Randomized Controlled Trial Comparing Tacrolimus/Sirolimus and Tacrolimus/Methotrexate (Blood and Marrow Transplant Clinical Trials Network/BMT CTN 0402). | 2019 Nov |
1 |
| 14 |
31385180 | Outcomes of sirolimus regimens in 65-year-old and older kidney transplant recipients: a registry-based observational study. | 2019 Nov |
1 |
| 15 |
31447189 | Preventive Role of mTOR Inhibitor in Post-Kidney Transplant Urothelial Carcinoma. | 2019 Oct |
2 |
| 16 |
29676018 | Conversion from tacrolimus-mycophenolate mofetil to tacrolimus-mTOR immunosuppression after kidney-pancreas transplantation reduces the incidence of both BK and CMV viremia. | 2018 Jun |
4 |
| 17 |
29757021 | Advagraf® with or without an induction therapy for de novo kidney-transplant recipients. | 2018 Jun |
1 |
| 18 |
28633129 | Inhibition effect of tacrolimus and platelet-derived growth factor-BB on restenosis after vascular intimal injury. | 2017 Sep |
1 |
| 19 |
26613512 | Effects of mTOR and calcineurin inhibitors combined therapy in Epstein-Barr virus positive and negative Burkitt lymphoma cells. | 2016 Jan |
1 |
| 20 |
24861504 | Focus on mTOR inhibitors and tacrolimus in renal transplantation: pharmacokinetics, exposure-response relationships, and clinical outcomes. | 2014 Jun |
1 |
| 21 |
25491391 | Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients. | 2014 Dec 10 |
1 |
| 22 |
22875481 | Inhibition of calcineurin in the prefrontal cortex induced depressive-like behavior through mTOR signaling pathway. | 2013 Jan |
2 |
| 23 |
23577651 | Long-term mTOR inhibitors administration evokes altered calcium homeostasis and platelet dysfunction in kidney transplant patients. | 2013 May |
1 |
| 24 |
23696253 | Everolimus: a guide to its use in liver transplantation. | 2013 Aug |
1 |
| 25 |
23839048 | FKBPs and the Akt/mTOR pathway. | 2013 Aug 1 |
1 |
| 26 |
20304212 | Rescue immunosuppression with mammalian target of rapamycin inhibitor drugs in liver transplantation. | 2010 Mar |
2 |
| 27 |
21182472 | FK506 binding proteins as targets in anticancer therapy. | 2010 Nov 1 |
1 |
| 28 |
19715866 | Efficacy, tolerance, and safety of mammalian target of rapamycin inhibitors as rescue immunosuppressants in liver transplantation. | 2009 Jul-Aug |
2 |
| 29 |
19081378 | Removal of FKBP12 enhances mTOR-Raptor interactions, LTP, memory, and perseverative/repetitive behavior. | 2008 Dec 10 |
2 |
| 30 |
17038582 | Impairment of T cell interactions with antigen-presenting cells by immunosuppressive drugs reveals involvement of calcineurin and NF-kappaB in immunological synapse formation. | 2007 Jan |
1 |
| 31 |
17645716 | Comparison of sirolimus and everolimus in their effects on blood lipid profiles and haematological parameters in heart transplant recipients. | 2007 Jul-Aug |
2 |
| 32 |
17175265 | Genomic profiling of kidney ischemia-reperfusion reveals expression of specific alloimmunity-associated genes: Linking "immune" and "nonimmune" injury events. | 2006 Dec |
1 |
| 33 |
12740386 | Mechanism of ribosomal p70S6 kinase activation by granulocyte macrophage colony-stimulating factor in neutrophils: cooperation of a MEK-related, THR421/SER424 kinase and a rapamycin-sensitive, m-TOR-related THR389 kinase. | 2003 Jul 25 |
2 |
| 34 |
11792863 | Insulin-stimulated phosphorylation of lipin mediated by the mammalian target of rapamycin. | 2002 Jan 22 |
1 |
| 35 |
10775131 | Fluid flow activates a regulator of translation, p70/p85 S6 kinase, in human endothelial cells. | 2000 May |
2 |